Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Kennedy Melina M

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP-Product Compl.-Reg. Affairs
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common 233.884 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right-to-Buy) 05/18/2015 05/18/2022 Common 50 97.2 D
Stock Option (Right-to-Buy) 08/07/2015 08/07/2022 Common 50 101.01 D
Stock Option (Right-to-Buy) 05/15/2015 05/15/2022 Common 50 102.97 D
Stock Option (Right-to-Buy) 04/04/2019 04/04/2026 Common 780 109.09 D
Stock Option (Right-to-Buy) 04/02/2016 04/02/2023 Common 145 111.84 D
Stock Option (Right-to-Buy) 12/26/2021 12/26/2028 Common 50 131.07 D
Stock Option (Right-to-Buy) 12/11/2021 12/11/2028 Common 100 134.4 D
Stock Option (Right-to-Buy) 06/23/2018 06/23/2025 Common 50 135.66 D
Stock Option (Right-to-Buy) 04/02/2018 04/02/2025 Common 360 136.82 D
Stock Option (Right-to-Buy) 07/31/2017 07/31/2024 Common 100 139.39 D
Stock Option (Right-to-Buy) 04/02/2017 04/02/2024 Common 210 149.34 D
Stock Option (Right-to-Buy) 04/03/2020 04/03/2027 Common 2,500 149.72 D
Stock Option (Right-to-Buy) 08/21/2020 08/21/2027 Common 50 152.06 D
Stock Option (Right-to-Buy) 04/03/2021 04/03/2028 Common 610 160.1 D
Stock Option (Right-to-Buy) 08/04/2020 08/04/2027 Common 50 160.16 D
Stock Option (Right-to-Buy) 04/04/2022 04/04/2029 Common 860 163.43 D
Explanation of Responses:
/s/ Mark Sifferlen, Attorney-In-Fact 10/28/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

	I, Melina M. Kennedy, Vice President - Product Compliance and Regulatory 
Affairs of Cummins Inc. (the "Corporation"), hereby authorize and designate each
  of Mark J. Sifferlen and Sharon R. Barner, my agent and attorney-in-fact, with
  full power of substitution, to:

	(1)	prepare and sign on my behalf any Form 3, Form 4 or Form 5 and any 
amendments thereto, under Section 16(a) of the Securities Exchange Act of 1934 
(the "Exchange Act") that are necessary or advisable for the undersigned to file
  under Section 16(a) and file the same with the Securities and Exchange 
Commission and each stock exchange on which the Corporation's stock is listed;

	(2)	prepare and sign on my behalf any Form 144 Notice, and any amendments 
thereto, pursuant to Rule 144 under the Securities Act of 1933 that is necessary
  or advisable for the undersigned to file pursuant to Rule 144 and file the 
same with the Securities and Exchange Commission; and

	(3)	do anything else which any of them in his or her discretion deems necessary
  or proper in connection with the foregoing.

       The undersigned hereby grants to each such attorney-in-fact full power 
and authority to do and perform any and every act and thing whatsoever 
requisite, necessary or proper to be done
 in the exercise of any of the rights 
and powers herein granted, as fully to all intents and purposes as the 
undersigned might or could do if personally present, with full power of 
substitution or revocation, hereby ratifying and confirming all that each such 
attorney-in-fact (or such attorney-in-fact's substitute or substitutes) shall 
lawfully do or cause to be done by virtue of this power of attorney and the 
rights and powers herein granted.  The undersigned acknowledges that each 
attorney-in-fact, in serving in such capacity at the request of the undersigned,
  is not assuming, nor is such attorney-in-fact's substitute or substitutes or 
the Corporation assuming, any of the undersigned's responsibilities to comply 
with the Exchange Act.
	This power of attorney shall become effective as of the date hereof and shall 
remain in effect as long as I am subject to Section 16 with respect to the 
Corporation, and shall not be affected by my subsequent disability or 
incompetence, unless otherwise revoked in writing by the undersigned.

		Signed:  /s/ Melina M. Kennedy